PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Symptom | C0275551|spontaneous bacterial peritonitis |
| Sentences | 13 |
| PubMedID- 24827481 | Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis. |
| PubMedID- 23402188 | spontaneous bacterial peritonitis in liver cirrhosis: optimization issues of prevention and treatment. |
| PubMedID- 24714550 | Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites. |
| PubMedID- 26064127 | Hsp in the adult population is rare, and no case has been described of hsp in liver cirrhosis with spontaneous bacterial peritonitis (sbp). |
| PubMedID- 22878533 | The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis. |
| PubMedID- 26493630 | A variant in the nuclear dot protein 52kda gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosis. |
| PubMedID- 23837137 | Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis. |
| PubMedID- 22706739 | Investigation into bacteremia and spontaneous bacterial peritonitis in patients with liver cirrhosis in japan. |
| PubMedID- 19844200 | Objectives: impaired intestinal permeability (ip) may have a role in the pathogenesis of ascites and in spontaneous bacterial peritonitis (sbp) in patients with liver cirrhosis (lc). |
| PubMedID- 25741536 | Nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis. |
| PubMedID- 24255734 | Prevalence of spontaneous bacterial peritonitis in liver cirrhosis with ascites. |
| PubMedID- 26039135 | The primary objective of this study was to determine the association between the use of gastric acid suppressants (gas) and the risk of developing spontaneous bacterial peritonitis (sbp) in patients with advanced liver cirrhosis (lc). |
| PubMedID- 24565286 | Treatment with intravenous ceftriaxone (2g/day) was started after a diagnosis of spontaneous bacterial peritonitis associated with liver cirrhosis was made. |
Page: 1